Bristol-Myers Squibb to Take Part in Leerink Swann Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Leerink Swann Global Healthcare Conference on Wednesday, February 10, 2016, in New York. Charles Bancroft, executive vice president and chief financial officer, will answer questions about the company at 1:25 p.m. EST.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160203005075/en/

Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
[email protected]
or
Investors:
Ranya Dajani, 609-252-5330
[email protected]
Bill Szablewski, 609-252-5894
[email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• BMS presents five-year Camzyos data for heart condition at ESC
• FirstEnergy Foundation Expands Fight Against Hunger With $5 Million Investment Across Six-State Region
• Action Behavior Centers' Family Advocacy Team Meets with Congressional Leaders in Washington, D.C., to Discuss Access to ABA Therapy for Autism